Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
Objective: Glucagon-like peptide (GLP)-1 is an incretin hormone that acts after food intake to stimulate insulin production, enhance satiety, and promote weight loss. Here we describe the discovery and characterization of ecnoglutide (XW003), a novel GLP-1 analog. Methods: We engineered a series of...
Saved in:
Main Authors: | Wanjun Guo (Author), Zheng Xu (Author), Haixia Zou (Author), Feng Li (Author), Yao Li (Author), Jing Feng (Author), Zhiyi Zhu (Author), Qing Zheng (Author), Rui Zhu (Author), Bin Wang (Author), Yan Li (Author), Sujuan Hao (Author), Hong Qin (Author), Catherine L. Jones (Author), Eric Adegbite (Author), Libnir Telusca (Author), Martijn Fenaux (Author), Weidong Zhong (Author), Mohammed K. Junaidi (Author), Susan Xu (Author), Hai Pan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019) -
Effects of exercise on glucagon-like peptide-1 (GLP-1)
by: Shin-ya Ueda, et al.
Published: (2013) -
Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations
by: Dan Xu, et al.
Published: (2022) -
Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
by: Magdalena Mazurek, et al.
Published: (2023) -
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
by: Qian Zhao, et al.
Published: (2024)